A detailed history of Talbot Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Talbot Financial, LLC holds 15,926 shares of LLY stock, worth $14.4 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares
15,926
Previous 15,664 1.67%
Holding current value
$14.4 Million
Previous $9.13 Billion 35.69%
% of portfolio
1.66%
Previous 1.37%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$592.2 - $792.28 $155,156 - $207,577
262 Added 1.67%
15,926 $12.4 Billion
Q4 2023

Jan 11, 2024

BUY
$525.19 - $619.13 $276,249 - $325,662
526 Added 3.47%
15,664 $9.13 Billion
Q3 2023

Oct 24, 2023

BUY
$434.7 - $599.3 $160,839 - $221,740
370 Added 2.51%
15,138 $8.13 Billion
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $27,357 - $36,580
78 Added 0.53%
14,768 $6.93 Billion
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $4.56 Million - $5.36 Million
14,690 New
14,690 $5.04 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Talbot Financial, LLC Portfolio

Follow Talbot Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Talbot Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Talbot Financial, LLC with notifications on news.